AP2alpha and AP2gamma: a comparison of binding site specificity and trans-activation of the estrogen receptor promoter and single site promoter constructs.
about
Identification of target genes of transcription factor activator protein 2 gamma in breast cancer cellsA family of AP-2 proteins down-regulate manganese superoxide dismutase expressionA novel zinc finger transcription factor with two isoforms that are differentially repressed by estrogen receptor-alphaSumoylation pathway is required to maintain the basal breast cancer subtypeDual association by TFAP2A during activation of the p21cip/CDKN1A promoterIdentification of primary gene targets of TFAP2C in hormone responsive breast carcinoma cellsAP-2gamma induces p21 expression, arrests cell cycle, and inhibits the tumor growth of human carcinoma cellsLigand-dependent interaction of estrogen receptor-alpha with members of the forkhead transcription factor familyHuman CREB-binding protein/p300-interacting transactivator with ED-rich tail (CITED) 4, a new member of the CITED family, functions as a co-activator for transcription factor AP-2Inhibition of neural crest formation by Kctd15 involves regulation of transcription factor AP-2Examination of transcriptional networks reveals an important role for TCFAP2C, SMARCA4, and EOMES in trophoblast stem cell maintenanceCloning and characterization of a novel mouse AP-2 transcription factor, AP-2delta, with unique DNA binding and transactivation propertiesRedundant activities of Tfap2a and Tfap2c are required for neural crest induction and development of other non-neural ectoderm derivatives in zebrafish embryos.Novel activator protein-2alpha splice-variants function as transactivators of the ovine placental lactogen gene.Identification of functional TFAP2A and SP1 binding sites in new TFAP2A-modulated genesExperimental and Computational Considerations in the Study of RNA-Binding Protein-RNA InteractionsDefining the regulatory factors required for epidermal gene expression.Tumor suppressor activity of AP2alpha mediated through a direct interaction with p53.AP-2alpha and AP-2gamma are transcriptional targets of p53 in human breast carcinoma cells.Transcriptional regulation of ULBP1, a human ligand of the NKG2D receptor.Two regions within the proximal steroidogenic factor 1 promoter drive somatic cell-specific activity in developing gonads of the female mouse.Human Melanoma cells over-express extracellular matrix 1 (ECM1) which is regulated by TFAP2C.The proteasome inhibitor bortezomib induces an inhibitory chromatin environment at a distal enhancer of the estrogen receptor-α gene.New insights into estrogen receptor function in human breast cancer.Conserved epigenetic sensitivity to early life experience in the rat and human hippocampus.Transcriptional regulation of the GPX1 gene by TFAP2C and aberrant CpG methylation in human breast cancer.Activator protein-2 in carcinogenesis with a special reference to breast cancer--a mini review.Expression of the RET proto-oncogene is regulated by TFAP2C in breast cancer independent of the estrogen receptor.High TFAP2C/low CD44 expression is associated with an increased rate of pathologic complete response following neoadjuvant chemotherapy in breast cancer.Silencing of CHD5 gene by promoter methylation in leukemia.Distinct pathways regulated by RET and estrogen receptor in luminal breast cancer demonstrate the biological basis for combination therapy.Genomic structure of the promoters of the human estrogen receptor-alpha gene demonstrate changes in chromatin structure induced by AP2gamma.The minimal promoter of the human alpha 3 nicotinic receptor subunit gene. Molecular and functional characterization.Critical role for transcription factor AP-2alpha in human trophoblast differentiation.Pituitary tumor AP-2alpha recognizes a cryptic promoter in intron 4 of fibroblast growth factor receptor 4.Identification of HTF (HER2 transcription factor) as an AP-2 (activator protein-2) transcription factor and contribution of the HTF binding site to ERBB2 gene overexpression.Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal CarcinomasAn autoregulatory loop directs the tissue-specific expression of p63 through a long-range evolutionarily conserved enhancer.KAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells.Cell cycle arrest and apoptosis induction by activator protein 2alpha (AP-2alpha) and the role of p53 and p21WAF1/CIP1 in AP-2alpha-mediated growth inhibition.
P2860
Q21260382-8646771E-0831-43BD-915E-A0281229B5A3Q24291015-91A19434-4E7F-4F3F-A83D-67092F182464Q24292107-80F7EDE4-8E54-446E-97D9-30D07B197FC1Q24297866-D133CC53-B192-4C00-BE4E-6B66D67E03A7Q24307618-AB4A15F0-DC98-4A05-9A82-8D01D39384F5Q24626014-569F68F3-B879-4B92-B2C1-9672073CB93CQ24676129-931F1230-C6C0-4F74-8282-5B39DC389A56Q28204523-D2B83726-BEE2-4CC8-96ED-8DBB48903121Q28211366-8E2AA5B0-8995-4689-9E46-D38B0CD29F85Q28312142-ACE394DE-A276-41CF-8FCA-3BA0DA3F7237Q28507082-14EA7643-5E30-4EF6-A6E2-8E6DA2D8E5B0Q28510687-7B8FD17D-7E4C-4A56-BB0E-FE88501845A1Q30496555-47AE6565-9044-47C8-93F5-5F63006869D5Q30664043-0BF220E6-901A-4525-97CB-05F2F906663AQ33595109-66450B58-1257-4253-AB97-D456CDCCEFC1Q33923485-E02E1D2A-5757-4B1B-8BD2-850B0668A0D8Q33962695-0F49F225-37A7-4CE0-8FAA-6CBE876BF5A6Q34149151-2F1C7ACF-EC53-4B1F-B94F-563B7A9DA051Q34517383-AFA2D15B-E71D-4857-86A0-085457EEFABEQ34556241-2EEBF7B0-B0A7-44F5-BBC8-72CD708C055EQ34594067-4632BC6D-53F5-4ABC-B81D-39B290680C4BQ34984600-C05F767D-D4E0-4930-A912-41FAACC7F7ADQ35067415-1BE0940C-104B-41D3-89FA-60E291052E94Q35622050-3452DFCE-8484-4259-ACE4-B61D1BC66D4AQ36336199-533738A1-D075-4A56-A2D4-F2BF1636B043Q36467928-5B9861AD-F317-4F3F-AAF0-A11EA6FC31E7Q36748207-1E4E0CA8-3EA4-4A5D-BFA0-09763D3FE452Q36970341-72E3C4C3-C133-415B-98C4-1CE401FA37EFQ37288041-0C693C6F-A05D-46AF-B3A0-A7F41A778237Q37472949-D1ECC5CE-DDE1-4E3D-B7CA-B75F173C98FCQ37701896-28FF78AA-8678-420D-8D74-4F6FA4C2532BQ38302692-42E8A72F-86A4-442B-88D6-F23EAB934524Q38307870-D2FCFC1D-5C83-4C32-99CF-8C6B995DC2A1Q38343281-F0583C93-6444-4F2C-9E07-B9093178F94DQ38356684-08E429DD-9347-4934-861D-479424D98115Q38361296-1674EC81-D4D1-403A-A7C0-B7796745B647Q38727673-8F5C6A5F-B37E-4CB8-A306-220F7E4CCDBAQ40297038-566837FD-F1C9-4778-AEF6-9E13D0878145Q40484635-AE9A8FA6-0BCB-4C13-B40C-D6E466C06C3DQ40627272-8B7AB7D1-C2AA-4E27-B0AF-BBD60F2F1DFF
P2860
AP2alpha and AP2gamma: a comparison of binding site specificity and trans-activation of the estrogen receptor promoter and single site promoter constructs.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
AP2alpha and AP2gamma: a compa ...... ngle site promoter constructs.
@en
AP2alpha and AP2gamma: a compa ...... ngle site promoter constructs.
@nl
type
label
AP2alpha and AP2gamma: a compa ...... ngle site promoter constructs.
@en
AP2alpha and AP2gamma: a compa ...... ngle site promoter constructs.
@nl
prefLabel
AP2alpha and AP2gamma: a compa ...... ngle site promoter constructs.
@en
AP2alpha and AP2gamma: a compa ...... ngle site promoter constructs.
@nl
P356
P1476
AP2alpha and AP2gamma: a compa ...... ingle site promoter constructs
@en
P2093
L A McPherson
P304
P356
10.1093/NAR/27.20.4040
P407
P577
1999-10-01T00:00:00Z